Skip to main content
رجوع
TGRNF logo

Tong Ren Tang Technologies Co. Ltd.

جودة البيانات: 100%
ذروة بيع
TGRNF
OTC Healthcare Drug Manufacturers - General
KWD 0.55
KWD 0.00 (0.00%)
القيمة السوقية: 704.42M
نطاق اليوم
KWD 0.55 KWD 0.55
نطاق 52 أسبوعًا
KWD 0.55 KWD 0.70
حجم التداول
1,000
متوسط 50 يوم / 200 يوم
KWD 0.69 / KWD 0.67
الإغلاق السابق
KWD 0.55

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 1.4 0.3
P/B 0.1 3.0
ROE % 7.4 3.7
Net Margin % 7.2 3.8
Rev Growth 5Y % 12.0 10.0
D/E 0.3 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 0.51
KWD 0.51 – KWD 0.51
8.73B 1
FY2026 KWD 0.46
KWD 0.46 – KWD 0.46
8.05B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2025-09-01 N/A KWD 0.04
2024-12-31 N/A KWD 0.01
2024-08-30 N/A KWD 0.05
2024-01-22 N/A KWD 0.02
2023-06-30 N/A KWD 0.04
2022-12-31 N/A KWD 0.03
2022-06-30 N/A KWD 0.04
2022-03-18 N/A KWD 0.02

Dividend History

Yield

0.04%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Jun 18, 2025 Aug 11, 2025 KWD 0.03 4.06%
Jun 18, 2024 Aug 09, 2024 KWD 0.02 3.60%
Jun 19, 2023 Aug 14, 2023 KWD 0.02 3.23%
Jun 20, 2022 Aug 15, 2022 KWD 0.02 3.85%
Jun 10, 2021 Aug 05, 2021 KWD 0.03 4.04%
Jun 22, 2020 Aug 17, 2020 KWD 0.02 3.03%
Jun 13, 2019 Aug 08, 2019 KWD 0.03 1.95%
Jun 14, 2018 Aug 10, 2018 KWD 0.03 1.79%
Jun 15, 2017 Aug 11, 2017 KWD 0.02 1.55%
Jun 21, 2016 Aug 15, 2016 KWD 0.02 1.56%
Jun 12, 2015 Aug 06, 2015 KWD 0.02 2.01%
Jun 17, 2014 Aug 08, 2014 KWD 0.04 2.92%
Jun 20, 2013 Jul 26, 2013 KWD 0.04 15.15%
May 24, 2012 Jul 12, 2012 KWD 0.03 0.27%
Apr 11, 2011 Jul 08, 2011 KWD 0.07 0.55%
May 17, 2010 Aug 31, 2010 KWD 0.07 0.42%
May 22, 2009 Aug 31, 2009 KWD 0.06 0.51%
May 15, 2008 Jul 30, 2008 KWD 0.06 0.51%
Apr 12, 2007 Aug 31, 2007 KWD 0.05 0.36%
Apr 12, 2006 Aug 31, 2006 KWD 0.46 2.95%

النقاط الرئيسية

Revenue grew 12.04% annually over 5 years — strong growth
Earnings declined -11.59% over the past year
Debt/Equity of 0.34 — conservative balance sheet
Negative free cash flow of -158.56M
P/E of 1.35 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.86%

النمو

Revenue Growth (5Y)
12.04%
Revenue (1Y)7.18%
Earnings (1Y)-11.59%
FCF Growth (3Y)N/A

الجودة

Return on Equity
7.40%
ROIC7.67%
Net Margin7.19%
Op. Margin13.57%

الأمان

Debt / Equity
0.34
Current Ratio3.81
Interest Coverage15.28

التقييم

P/E Ratio
1.35
Forward P/EN/A
P/B Ratio0.10
EV/EBITDA-1.01
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.18% Revenue Growth (3Y) 10.07%
Earnings Growth (1Y) -11.59% Earnings Growth (3Y) -5.39%
Revenue Growth (5Y) 12.04% Earnings Growth (5Y) 2.78%
Profitability
Revenue (TTM) 7.26B Net Income (TTM) 521.80M
ROE 7.40% ROA 3.62%
Gross Margin 39.64% Operating Margin 13.57%
Net Margin 7.19% Free Cash Flow (TTM) -158.56M
ROIC 7.67% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.34 Current Ratio 3.81
Interest Coverage 15.28
Dividends
Dividend Yield 0.04% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 1.35 Forward P/E N/A
P/B Ratio 0.10 P/S Ratio 0.10
PEG Ratio -1.13 Forward PEG N/A
EV/EBITDA -1.01 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22.51%
Market Cap 704.42M Enterprise Value -999.86M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 7.26B 6.77B 5.99B 5.40B 4.61B
Net Income 521.80M 590.19M 582.89M 507.25M 467.55M
EPS (Diluted) 0.41 0.46 0.46 0.40 0.37
Gross Profit 2.88B 2.85B 2.59B 2.29B 2.07B
Operating Income 985.16M 1.12B 1.21B 1.08B 943.55M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 14.41B 13.51B 12.48B 11.59B 10.94B
Total Liabilities 4.24B 3.86B 3.47B 3.44B 3.19B
Shareholders' Equity 7.21B 6.89B 6.48B 5.98B 5.73B
Total Debt 2.43B 1.63B 1.59B 1.64B 1.69B
Cash & Equivalents 4.13B 2.75B 3.72B 3.25B 2.95B
Current Assets 10.83B 10.06B 9.07B 8.13B 7.45B
Current Liabilities 2.84B 2.24B 2.05B 2.46B 2.45B

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches

النشاط الأخير

دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026